Procurement Report: Vegetal Vigra 200mg (Sexual Enhancement)

Product Category: Dietary Supplement / Unregulated Sexual Enhancement Product Risk Status: CRITICAL / PROHIBITED Primary Regulatory Alert: U.S. Food and Drug Administration (FDA) Warning (August 2023)

---

1. Technical Specifications and Performance Metrics

Critical Warning: The product "Vegetal Vigra 200mg" does not possess valid, verified technical specifications for a dietary supplement. Laboratory analysis by the U.S. FDA has confirmed that this product contains undeclared sildenafil (the active ingredient in the prescription drug Viagra) at undisclosed dosages.

• Active Ingredient: Sildenafil (Undeclared/Hidden).
• Declared Dosage (Label): 200mg (Claimed).
• Actual Dosage: Unknown/Unverified (FDA analysis confirmed presence, but exact concentration relative to label claims is not certified).
• Performance Metrics:
  • Onset of Action: Variable and unregulated (typical for undeclared drugs: 30–60 minutes).
  • Duration of Effect: Unverified (typical for sildenafil: 4–6 hours).
  • Safety Profile: Non-existent. No clinical trials or safety data exist for this specific formulation.
  • Purity: 0% Verified. Contains hidden pharmaceutical compounds not listed on the label.

Actionable Recommendation: DO NOT procure this product. The "technical specifications" are fraudulent. Procuring this item exposes the buyer to severe liability, health risks, and regulatory penalties. The presence of hidden sildenafil at unknown dosages creates an unpredictable pharmacological profile that cannot be engineered or controlled.

2. Industry Compliance and Quality Assurance

Regulatory Status: Non-Compliant / Illegal for Sale in the U.S. Market.

• FDA Compliance: Failed. The FDA explicitly issued a public advisory (August 9, 2023) advising consumers and retailers not to purchase or use Vegetal Vigra 200mg. It is classified as an adulterated drug.
• Labeling Compliance: Failed. The product fails to disclose its active pharmaceutical ingredient (sildenafil), violating the Federal Food, Drug, and Cosmetic Act.
• Quality Assurance (QA): Non-Existent. There is no evidence of Good Manufacturing Practices (GMP) certification. The presence of hidden drugs indicates a lack of quality control, likely involving cross-contamination or intentional adulteration.
• Distribution Channel: Distributed by APG Seven, Inc., identified by the FDA as a distributor of this non-compliant product.

Actionable Recommendation: Implement a zero-tolerance policy for this product in all procurement channels. Any vendor offering "Vegetal Vigra 200mg" or similar "herbal" products with exaggerated potency claims must be immediately flagged for compliance review. Procurement teams should utilize third-party testing services to screen for undeclared sildenafil in all sexual enhancement supplements before purchase.

3. Cost Efficiency and Integration Capabilities

Cost Analysis:

• Unit Cost: Variable (Typical B2B range for unregulated supplements: $15–$40 per unit, depending on volume).
• Hidden Costs:
  • Legal Liability: Potential fines for selling adulterated drugs (FDA warning letters, seizure of goods).
  • Recall Costs: Estimated $50,000–$500,000+ for logistics, disposal, and legal defense.
  • Brand Damage: Irreputable market positioning.
• Integration Capabilities: None. This product cannot be integrated into a legitimate supply chain, pharmacy network, or regulated retail environment. It cannot be listed on compliant e-commerce platforms (e.g., Amazon, major pharmacy chains) without immediate removal and potential account suspension.

Actionable Recommendation: Calculate the Total Cost of Ownership (TCO) including the risk of litigation. The "savings" from buying unregulated bulk stock are negligible compared to the risk of regulatory action. Redirect procurement budget toward FDA-compliant, third-party tested alternatives.

4. Typical Use Cases

Intended Use (Per Marketing): Sexual enhancement and treatment of erectile dysfunction (ED). Actual Use (Per FDA): Unregulated administration of prescription-grade sildenafil.

• Scenario A (Consumer): Individuals seeking immediate ED relief without a prescription.
  • Risk: High probability of adverse drug interactions, particularly with nitrates (nitroglycerin) used for heart conditions.
• Scenario B (Retailer): Selling "herbal" supplements with high potency claims to increase margins.
  • Risk: Immediate FDA enforcement action, product seizure, and civil penalties.
• Scenario C (Distributor): Moving product through gray-market channels.
  • Risk: Criminal liability for distributing misbranded and adulterated drugs.

Actionable Recommendation: There are no legitimate use cases for this product in a compliant business environment. Procurement strategies should focus on products with clear, verified indications and approved labeling.

5. Long-Term Planning Considerations

Market Trends and Demand Signals:

• Regulatory Crackdown: The FDA and international regulatory bodies are increasingly using advanced laboratory screening to detect hidden drugs (sildenafil, tadalafil, etc.) in "natural" supplements.
• Consumer Awareness: Growing demand for transparency and third-party testing (e.g., USP, NSF, ConsumerLab) in the sexual health market.
• Supply Chain Resilience: Reliance on unregulated suppliers creates high supply chain volatility due to sudden seizures and bans.

Strategic Outlook:

• Risk of Obsolescence: Products like Vegetal Vigra are high-risk targets for future bans.
• Shift to Compliance: The market is shifting toward "clean label" supplements with verified ingredients or FDA-approved prescription pathways.
• Inventory Planning: Do not stock this product. Inventory holding periods for non-compliant goods should be zero to avoid seizure.

Actionable Recommendation: Develop a Supplier Vetting Protocol that includes mandatory Certificate of Analysis (CoA) review for undeclared ingredients. Plan for a transition to compliant product lines that can withstand regulatory scrutiny. Monitor FDA warning letters for emerging trends in adulterated sexual health products.

6. Special Product Recommendations

The following table compares the prohibited "Vegetal Vigra 200mg" against compliant alternatives.

| Product Type | Best-Fit Buyer | Key Specs | Risk Check | Procurement Advice | | :--- | :--- | :--- | :--- :--- | | Vegetal Vigra 200mg | None | Hidden Sildenafil; No GMP; FDA Warning | Critical (Adulterated Drug) | AVOID. Do not procure. High legal/health risk. | | FDA-Approved Sildenafil (Viagra) | Clinics, Pharmacies | 25mg/50mg/100mg; Rx Only; Verified Purity | Low (Regulated) | Procure via licensed pharmaceutical distributors only. | | Third-Party Tested Herbal ED | Retailers, E-commerce | L-Citrulline, Ginseng; NSF/USP Certified; No hidden drugs | Low (If Certified) | Verify CoA for undeclared ingredients. Check for "FDA Warning" history. | | Lifestyle Supplements (General) | General Retail | Vitamins, Minerals; GMP Certified | Low | Standard procurement; ensure supplier has clean FDA record. |

Actionable Recommendation: Replace any consideration of "Vegetal Vigra" with FDA-approved prescription channels or third-party tested herbal supplements. Ensure all new SKUs undergo independent laboratory testing for undeclared pharmaceuticals before listing.

7. Frequently Asked Questions (FAQ)

Q1: Is Vegetal Vigra 200mg safe to purchase for resale? A: No. The FDA has confirmed it contains hidden sildenafil and issued a public warning advising against its use or purchase. Reselling it is illegal and poses severe health risks.

Q2: What happens if I buy this product in bulk? A: The product is subject to seizure by federal authorities. You may face civil penalties, fines, and potential criminal charges for distributing an adulterated drug.

Q3: Does "Vegetal" mean it is natural and safe? A: No. The "Vegetal" branding is misleading. The product contains a synthetic prescription drug (sildenafil) not listed on the label, making it unsafe and non-compliant.

Q4: Can I test this product myself to ensure it is safe? A: While you can test for ingredients, the presence of hidden drugs indicates a systemic failure in manufacturing. Even if a batch tests positive for sildenafil, the dosage is uncontrolled, making it unsafe for consumption.

Q5: Are there any legitimate suppliers for this specific product name? A: No. The product is associated with APG Seven, Inc., which has been flagged by the FDA. No legitimate, compliant supplier should be marketing this specific item.

Q6: What are the health risks of using this product? A: The hidden sildenafil can cause dangerous drops in blood pressure, especially if the user is taking nitrates (common for heart conditions). It can lead to heart attack, stroke, or death.

Q7: How can I verify if a sexual enhancement product is safe? A: Check the FDA website for warning letters, look for third-party testing seals (USP, NSF), and ensure the product lists all active ingredients clearly on the label.

Q8: What is the lead time for compliant alternatives? A: For FDA-approved drugs, lead time depends on pharmacy licensing (typically 1–3 days). For compliant herbal supplements, typical B2B lead times are 2–4 weeks with standard MOQs.